CoChat

Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation

Open access
Li, Sichen, Chou, Arthur P., Chen, Weidong, Chen, Ruihuan, Deng, Yuzhong, Phillips, Heidi S., Selfridge, Julia, Zurayk, Mira, Lou, Jerry J., Everson, Richard G., Wu, Kuan-Chung, Faull, Kym F., Cloughesy, Timothy, Liau, Linda M., Lai, Albert · 2013 · Neuro-Oncology
Cited by 155

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Mutations in isocitrate dehydrogenase 1 (IDH1) or 2 (IDH2) are found in a subset of gliomas. Among the many phenotypic differences between mutant and wild-type IDH1/2 gliomas, the most salient is that IDH1/2 mutant glioma patients demonstrate markedly improved survival compared with IDH1/2 wild-type glioma patients. To address the mechanism underlying the superior clinical outcome of IDH1/2 mutant glioma patients, we investigated whether overexpression of the IDH1(R132H) protein could affect response to therapy in the context of an isogenic glioma cell background. Stable clonal U87MG and U373MG cell lines overexpressing IDH1(WT) and IDH1(R132H) were generated, as well as U87MG cell lines overexpressing IDH2(WT) and IDH2(R172K). In vitro experiments were conducted to characterize baseline growth and migration and response to radiation and temozolomide. In addition, reactive oxygen species (ROS) levels were measured under various conditions. U87MG-IDH1(R132H) cells, U373MG-IDH1(R132H) cells, and U87MG-IDH2(R172K) cells demonstrated increased sensitivity to radiation but not to temozolomide. Radiosensitization of U87MG-IDH1(R132H) cells was accompanied by increased apoptosis and accentuated ROS generation, and this effect was abrogated by the presence of the ROS scavenger N-acetyl-cysteine. Interestingly, U87MG-IDH1(R132H) cells also displayed decreased growth at higher cell density and in soft agar, as well as decreased migration. Overexpression of IDH1(R132H) and IDH2(R172K) mutant protein in glioblastoma cells resulted in increased radiation sensitivity and altered ROS metabolism and suppression of growth and migration in vitro. These findings provide insight into possible mechanisms contributing to the improved outcomes observed in patients with IDH1/2 mutant gliomas.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/neuonc/nos261

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 155

Metadata

Authors
Li, S., Chou, A. P., Chen, W., Chen, R., Deng, Y., Phillips, H. S., Selfridge, J., Zurayk, M., Lou, J. J., Everson, R. G., Wu, K.-C., Faull, K. F., Cloughesy, T., Liau, L. M., & Lai, A.
Venue
Neuro-Oncology
Published
2012-10-31
Volume
15
Issue
1
Pages
57-68
ISSN
  • 1522-8517 (ISSN-L)
  • 1523-5866
OpenAlex
W2148339251
Cited by
155
References
16
FWCI
4.86
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation. https://app.cochat.ai/papers/10.1093/neuonc/nos261
The paper
Li, S., Chou, A. P., Chen, W., Chen, R., Deng, Y., Phillips, H. S., Selfridge, J., Zurayk, M., Lou, J. J., Everson, R. G., Wu, K.-C., Faull, K. F., Cloughesy, T., Liau, L. M., & Lai, A. (2013). Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation. Neuro-Oncology. https://doi.org/10.1093/neuonc/nos261

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.